Synairgen (LON:SNG) Share Price Passes Below Two Hundred Day Moving Average – Here’s Why

Synairgen plc (LON:SNG)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2.80 ($0.04) and traded as low as GBX 0.67 ($0.01). Synairgen shares last traded at GBX 0.93 ($0.01), with a volume of 2,846,631 shares.

Synairgen Trading Down 2.6 %

The stock has a market cap of £9.04 million, a price-to-earnings ratio of -0.56 and a beta of -2.23. The stock has a 50-day moving average price of GBX 1.35 and a two-hundred day moving average price of GBX 2.78.

Synairgen Company Profile

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).